Innate Immune Recognition of B. anthracis
Innate Immune Recognition of B. anthracis
批准号:
7530781
负责人:
MOLLY A HUGHES
金额:
$22.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-09 至 2010-05-31
关键词:
AerosolsAnimalsAnthrax diseaseAntibioticsBacillus (bacterium)Bacillus anthracisBacillus anthracis sporeBreathingCell LineCellsDevelopmentElementsEncapsulatedExposure toFoundationsFutureGoalsHealth PersonnelHealth ProfessionalHumanImmuneImmune responseImmune systemImmunologic ReceptorsImmunotherapeutic agentIn VitroInfectionInvadedKnowledgeLifeMethodsModelingMouse StrainsMusOrganismPathway interactionsPublic HealthRateReproduction sporesResearchResearch ProposalsSerumSudden DeathTLR2 geneTLR4 geneTestingTissuesToll-Like Receptor 2Toll-like receptorsaerosolizedbasecytokinefallsfightingin vivokillingsmacrophagemortalitypathogenpreventreceptorresponsetherapeutic vaccine
中文摘要
描述(由申请人提供):2001年秋季人类炭疽病例引起的关注增加了我们对气溶胶暴露后宿主对炭疽芽孢杆菌感染反应的更全面了解的需求。炭疽芽胞杆菌杀死宿主的机制尚不清楚,但即使给予适当的抗生素,接触气溶胶后死亡率也很高。这表明炭疽芽胞杆菌可能能够在感染后逃避或破坏宿主反应的一个或多个要素。先天免疫系统通常提供对入侵病原体的第一个识别和防御。宿主先天免疫细胞具有一系列受体,用于感知、识别和启动对入侵病原体的反应;这些受体包括toll样受体和细胞内NOD受体。该项目的总体目标是促进我们对宿主对炭疽杆菌的先天免疫反应的理解。随着对免疫识别途径和宿主免疫反应的更好理解,我们未来的目标将是确定免疫调节策略,以帮助预防在感染炭疽芽胞杆菌的宿主中通常观察到的快速,突然死亡。本建议的具体目标是鉴定识别炭疽芽孢杆菌和芽孢杆菌的宿主先天免疫受体。在特异性目标1中,我们将使用转染了选定受体的细胞系确定生物体与宿主相互作用激活的途径和受体。初步结果提示toll样受体2和myd88依赖性通路参与了该反应。在特异性目标2中,我们将使用小鼠气溶胶攻击模型确定包括toll样受体2在内的相关先天免疫受体对保护宿主免受吸入性炭疽感染的贡献。更全面地了解炭疽杆菌与宿主的相互作用,将使我们能够评估以动物为基础的炭疽杆菌疫苗和治疗方法的研究,为炭疽定向免疫治疗的发展提供基础,并提供适用于多种细菌病原体的重要基础信息。公共卫生相关性:炭疽芽孢杆菌是引起炭疽的细菌病原体。吸入形式的炭疽通常会导致宿主突然死亡,尽管卫生保健工作者早期识别感染并早期使用抗生素,如2001年秋季炭疽病例所见。这项研究的目的是确定炭疽芽孢杆菌如何与宿主的免疫系统相互作用,以便为医护人员设计帮助对抗感染的策略。
英文摘要
DESCRIPTION (provided by applicant): Concerns resulting from the human anthrax cases in the Fall of 2001 have increased our need for a more complete understanding of the host response to Bacillus anthracis infection following aerosol exposure. The mechanism by which B. anthracis kills the host remains unknown, but mortality is high following aerosol exposure even when appropriate antibiotics are administered. This suggests that B. anthracis may be capable of evading or subverting one or more elements of the host response following infection. The innate immune system typically provides the first recognition of and defense against invading pathogens. Host innate immune cells have a repertoire of receptors for sensing, recognizing, and initiating responses to invading pathogens; these receptors include Toll-like receptors and intracellular NOD receptors. The overall goal of this project is to advance our understanding of the host innate immune response to B. anthracis. With a better understanding of the immune recognition pathways and host immune response, our future goal will be to identify immunomodulatory strategies to help prevent the rapid, sudden death typically observed in a host infected with B. anthracis. The specific goals of this proposal are to identify those host innate immune receptors that recognize B. anthracis spores and bacilli. In Specific Aim 1, we will determine the pathways and receptors activated by the interaction of the organism with the host using cell lines transfected with selected receptors. Preliminary results implicate Toll-like receptor 2 and MyD88-dependent pathways in this response. In Specific Aim 2, we will determine the contribution of the relevant innate immune receptors including Toll-like receptor 2 to protection of the host from inhalational anthrax infection using a mouse aerosol challenge model. A more complete understanding of the interaction of B. anthracis with the host will allow us to evaluate animal-based studies of B. anthracis vaccines and therapeutics, provide a foundation for the development of anthrax-directed immunotherapeutics, and provide important fundamental information applicable to a diverse group of bacterial pathogens. PUBLIC HEALTH RELEVANCE: Bacillus anthracis is the bacterial pathogen that causes anthrax. The inhaled form of anthrax typically results in sudden death of the host in spite of early recognition of the infection by healthcare workers and early use of antibiotics, as was seen with the anthrax cases in the Fall of 2001. The goal of this research is to determine how Bacillus anthracis interacts with the host's immune system in order to devise strategies for healthcare workers to help fight the infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10468194
-
项目类别:
-
资助金额:$60.65万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10676878
-
项目类别:
-
资助金额:$61.31万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10120102
-
项目类别:
-
资助金额:$59.88万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10269939
-
项目类别:
-
资助金额:$63.1万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:8646871
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:8822201
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:8435665
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:9029273
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
2011 Chemical & Biological Terrorism Defense Gordon Research Conference (GRC) and
-
批准号:8052353
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2010
-
负责人:MOLLY A HUGHES
-
依托单位:
2009 Chemical and Biological Terrorism Defense Gordon Research Conference
-
批准号:7608881
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2008
-
负责人:MOLLY A HUGHES
-
依托单位:
Innate Immune Recognition of B. anthracis
-
批准号:7633403
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2008
-
负责人:MOLLY A HUGHES
-
依托单位:
Studies on Macrophage Resistance to Anthrax Lethal Toxin
-
批准号:6804467
-
项目类别:
-
资助金额:$26.62万
-
财政年份:2003
-
负责人:MOLLY A HUGHES
-
依托单位:
Studies on Macrophage Resistance to Anthrax Lethal Toxin
-
批准号:6676407
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2003
-
负责人:MOLLY A HUGHES
-
依托单位:
Identification of E. histolytica virulence factors
-
批准号:6423015
-
项目类别:
-
资助金额:$12.22万
-
财政年份:2002
-
负责人:MOLLY A HUGHES
-
依托单位:
Identification of E. histolytica virulence factors
-
批准号:6770139
-
项目类别:
-
资助金额:$12.22万
-
财政年份:2002
-
负责人:MOLLY A HUGHES
-
依托单位:
Identification of E. histolytica virulence factors
-
批准号:6603149
-
项目类别:
-
资助金额:$12.22万
-
财政年份:2002
-
负责人:MOLLY A HUGHES
-
依托单位:
海外基金